Cargando…
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
Respiratory syncytial virus (RSV) is a globally prevalent cause of lower respiratory infection in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has remained elusive. In recent years, improved understanding of RSV biology and innovations in immunogen design has re...
Autores principales: | Modjarrad, Kayvon, Giersing, Birgitte, Kaslow, David C., Smith, Peter G., Moorthy, Vasee S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858870/ https://www.ncbi.nlm.nih.gov/pubmed/26100926 http://dx.doi.org/10.1016/j.vaccine.2015.05.093 |
Ejemplares similares
-
Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015()
por: Giersing, Birgitte K., et al.
Publicado: (2016) -
Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016
por: Giersing, Birgitte K., et al.
Publicado: (2019) -
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016
por: Kobayashi, Miwako, et al.
Publicado: (2019) -
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
por: Modjarrad, Kayvon, et al.
Publicado: (2016) -
Agenda of 105th LHCC Meeting to be held on 23 & 24 March 2011
por: CERN. Geneva. The LHC experiments Committee
Publicado: (2011)